Completed PHASE2 INTERVENTIONAL NCT00093860

Propranolol to Treat Fainting in Children With Sympathoadrenal Imbalance

Propranolol for Syncope With Sympathoadrenal Imbalance in Children

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Conditions Syncope

Interventions Propranolol

Updated 5 times since 2017 Last updated: Mar 3, 2008 Started: Oct 31, 2004 Completion: Mar 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00093860, this PHASE2 trial focuses on Syncope and remains completed. Sponsored by National Institute of Neurological Disorders and Stroke (NINDS), it has been updated 5 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Oct 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Neurological Disorders and Stroke (NINDS)

Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States